chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient had symptoms of itchiness on her head a few hours after the injection. The next day she woke up with a red itchy rash around her neck that spread to her whole body by mid afternoon & was taken to the ER. They gave her an IV of Benadryl along with pepcid and she was sent home. She continued to have the itchy welt like rash that was painful for two weeks, she expeirenced it inside her throat from her head to her toes. She was given predensone, which the dosage was increased 2 ays after because it wasnt doing anything. The week of the shot she was seen at the ER twice and the Dr office once. The second ER visit they said the only thing they could do was give her adrenaline which I didnt do. She has since then been taking a pepcid daily, along with benadryl and zyrtec. She still gets the itchy rash (not as severe) cosistantly every day.
Abdominal pain; Cramp; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EP6955), via an unspecified route of administration in the left arm on 31Mar2021 at 10:30 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history included pollen allergy. Concomitant medications included vitamin D (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EL3247), via an unspecified route of administration in the left arm on 10Mar2021 at 10:30 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 10:00, after 24 hours of vaccination, the patient experienced abdominal pain and cramp for 3 hours. The patient did not receive any treatment for the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the abdominal pain and cramp was resolved on 01Apr2021.   No follow-up attempts are needed. No further information is expected.
patient was given insufficient dose of pfizer vaccine, was given 0.18 ml of vaccine when supposed to receive 0.30ml
Worsening arm pain after injection that eventually resulted in my being diagnosed with a blood clot in the arm that I recevied the injection on
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended and/or prescribed the ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. In 2011, a health care provider administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). On or about 01-AUG-2016, the patient was treated by a physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of his injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
Induration 4.5 cm x 4 cm. Erythema 6 cm x 9 cm.
POST VACCINE, STARTED FEELING HOT/SWEATY, NAUSEOUS, THEN WENT TO STAND UP AND FELT DIZZY. BROUGHT TO OBS TO LAY DOWN, VSS. SAT UP AS S/S RESOLVED, EXCEPT NAUSEA. SNACK AND WATER PROVIDED. ESCORTED TO EXIT WITH NO FURTHER ISSUES VIA WC ONCE NAUSEA RESOLVED AT 1240. 1210  BP 166/89 HR 88 SATS 97% RA 1220 BP 159/77 HR 87 SATS 97% RA 1230 STANDING  BP 145/70 HR 97 SATS 97% RA
Potential anaphylactic type reaction; Difficulty breathing; Tightness in throat; Pain that was shooting to neck and back; Pain that was shooting to neck and back; Pain that was shooting to neck and back; Site reaction with redness; This spontaneous case was received on 17-Feb-2021 from other health professional via Agency (reference number: SEQW21-00550) and concerned female patient of an unknown age.  The patient's medical history and concomitant medications were not provided.   On an unspecified date in Oct-2015, the patient was vaccinated with Afluria Quadrivalent (influenza vaccine, dose, route of administration and anatomical location: not reported) as influenza prophylaxis. The batch number reported was U50309.  On an unknown date in 2015, an unknown amount of time after receiving Afluria Quadrivalent, the patient had an allergic reaction to Afluria. She experienced site reaction with redness, pain that was shooting to neck and back. Nurse stated that the patient had potential anaphylactic type reaction as she woke in the middle of the night and had difficulty breathing and tightness in throat. Patient did not seek medical attention immediately.   On an unknown date in fall or winter, the patient was seen by medicine doctor (MD) to discuss the incident and was referred to a dermatologist. The patient had not had a flu shot since then.  The outcome of the events was not reported.   The reported assessed the events as related to Afluria Quadrivalent. Patient had an allergic reaction to Afluria in 2015.  The events of 'anaphylactic type reaction', difficulty breathing and tightness in throat were considered to be medically significant by a Physician within Seqirus's Pharmacovigilance and Risk Management Department.  Company comment:The patient developed anaphylactoid reaction, dyspnoea, throat tightness, neck pain, pain, back pain and vaccination site erythema after vaccination with the suspect product, Afluria Quadrivalent. Although onset date for the events was not provided, narrative suggested plausible temporal relationship. The patient's medical history and concomitant medications were not provided. Considering all above mentioned, causal relationship for all events is assessed as possibly related (defaults to ''related'' in the safety database for reporting purposes).; Reporter's Comments: Patient had an allergic reaction to Afluria in 2015.; Sender's Comments: The patient developed anaphylactoid reaction, dyspnoea, throat tightness, neck pain, pain, back pain and vaccination site erythema after vaccination with the suspect product, Afluria Quadrivalent. Although onset date for the events was not provided, narrative suggested plausible temporal relationship. The patient's medical history and concomitant medications were not provided. Considering all above mentioned, causal relationship for all events is assessed as possibly related (defaults to ''related'' in the safety database for reporting purposes).
pruritic  papular rash on nostril and lower lip, reported lower lip swelling. associated with headache, fatigue and arm soreness
I was swallowing deli turkey meat and the food was stuck in my esophagus. I had severe chest pain, and I repeatedly threw up the contents. I also coughed up blood and a clot. I attempted to drink fluid and it was unable to pass threw the esophagus and I threw up the fluid. I went to the emergency room yesterday around 4:00PM. They completed bloodwork which was normal. They also recommended a CT scan of my neck and recommended gastroenterologist. The symptoms did improve within a half an hour. I have not fully recovered as my esophagus lining still has to heal.
Dizziness, Headache, Myalgia, Fatigue, Dizziness, Vertigo. Narrative:
48 hrs after left thigh swelling and erythema, no fever. Taken to ER given KEFLEX, BENADRYL and ibuprofen.
This spontaneous report as received from a Medical Assistant refers to a patient of an unknown age and gender. The patient's concurrent conditions, medical history, historical drugs and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with improperly stored VAQTA lot number N017094, expiration date 31-AUG-2018 (dose and route were not reported) for prophylaxis. No adverse effect was reported. Temperature: 9 grades Celsius to 25 grades Celsius "(10.1 C)". Time frame: 1 hour and 56 minutes. There was no previous temperature excursion involved. This is one of several reports received from the same source. Sender's Comments: US-009507513-1710USA003169: Original Case: 1710USA003115, US-009507513-1710USA003166: Original Case: 1710USA003115, US-009507513-1710USA003115: Original Case: 1710USA003115, US-009507513-1710USA003168: Original Case: 1710USA003115, US-009507513-1710USA003164: Original Case: 1710USA003115, US-009507513-1710USA003163: Original Case: 1710USA003115, US-009507513-1710USA003165: Original Case: 1710USA003115.
Low grade fever, site injection pain and redness, fatigue, achy for 2 days
my hair is falling out. I have long brown hair, I began to notice 3 days after the vaccine that my hair brush was Very full, its been coming out heavily every day since. It looks very thin around my t; This is a spontaneous report from a contactable consumer or other non hcp (herself). A 35-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 20May2021 (Batch/Lot Number: EW0176) as dose 1, single (age at vaccination 35-year-old) for covid-19 immunisation. Medical history included drug known allergies: Sulfa from an unknown date and unknown if ongoing. Concomitant medication(s) included citalopram (CITALOPRAM) taken for an unspecified indication, start and stop date were not reported. Since the vaccination, the patient had not been tested for COVID-19. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced my hair is falling out. i have long brown hair, i began to notice 3 days after the vaccine that my hair brush was very full, its been coming out heavily every day since. it looks very thin around my temples. And the hair is everywhere I look. on 23May2021. No treatment was received. The outcome for event was not recovered.   Follow-up attempts are completed. No further information is expected.
pin-prickly-like tingling on her back; hot on her arm at the injection; felt a little bit of nausea; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (pin-prickly-like tingling on her back), VACCINATION SITE WARMTH (hot on her arm at the injection) and NAUSEA (felt a little bit of nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (pin-prickly-like tingling on her back), VACCINATION SITE WARMTH (hot on her arm at the injection) and NAUSEA (felt a little bit of nausea). At the time of the report, PARAESTHESIA (pin-prickly-like tingling on her back), VACCINATION SITE WARMTH (hot on her arm at the injection) and NAUSEA (felt a little bit of nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  Treatment medications was not provided by the reporter
Febrile seizure fever 101 - felt nauseated fell back fainted pale in face eyes rolled back total body shaking no incontinence lasted 2-3 min.
This case was reported by a physician via sales rep and described the occurrence of Guillain Barre syndrome in a 54-year-old female patient who received BOOSTRIX for prophylaxis. On 22nd June 2018, the patient received BOOSTRIX. On 16th July 2018, 24 days after receiving BOOSTRIX, the patient experienced Guillain Barre syndrome (serious criteria hospitalization and GSK medically significant), tingling of extremity (serious criteria hospitalization), numbness in feet (serious criteria hospitalization), back pain (serious criteria hospitalization), lip pain (serious criteria hospitalization) and numbness of tongue (serious criteria hospitalization). The patient was treated with Immunoglobulin. On an unknown date, the outcome of the Guillain Barre syndrome was not recovered/not resolved and the outcome of the tingling of extremity, numbness in feet, back pain, lip pain and numbness of tongue were unknown. It was unknown if the reporter considered the Guillain Barre syndrome, tingling of extremity, numbness in feet, back pain, lip pain and numbness of tongue to be related to BOOSTRIX. Additional details were provided as follows: The age at vaccination was not reported. The physician reported that a nurse practitioner who works in her office received BOOSTRIX. On 16th July 2018, she started experiencing numbness and tingling in her hands and feet. This got worse and worse and she experienced severe back and lip pain and her tongue went numb. She sent to the emergency room previous week of reporting date, had multiple laboratory tests, computed tomography (CT) and Magnetic Resonance Imaging (MRI). She saw a neurologist and had a repeat MRI and Guillain-Barre was eventually diagnosed based upon a lumbar puncture. On Friday, 3rd August 2018, she was admitted to the hospital and was currently in progressive care unit (PCU) getting intravenous immunoglobulin (IVIG).
pt states later in the day after the vax she noticed her neck, arm  and upper back was sore.  She went to bed since she wasn't feeling well.   She woke up feeling a little dizzy and foggy.  Pt got up next day but fainted after getting out of bed.  After coming to she stood up and then passed out again.  She had intense fatigue and headache.  Pt states that she is better but still has fatigue but has not appetite.  Pt has not contacted her PCP since her symptoms were getting better.
Flu vaccine received 10-19-15. No reaction on eve of 10-20-15 site of injection became red, hot, raised and itchy. Area approx 3" diameter, 10-21-15 red.
arm swelled up & redness covered most of upper arm; returned to hosp next day adm; IV ATB;
First few days post injection pain in arm, lasted 3 days. Now I have a large red circle of erythema at the injection site 8 days post injection. A little irritation lingers, no more pain, but the patch of redness persists.
Severe headache and chills, bedridden for two days.  On the second day, extreme bright red rash started around neck area, causing great discomfort.  Had to visit doctor as was impossible to function normally and needed rash taken care of.  I had specifically visited two different doctors, my primary care physician and an allergist because I had paralysis after a measles booster was administered to me when I was 17.  Neither was able to isolate why that happened and both encouraged me to receive the vaccine.  Then my work made it mandatory and I was forced to do it.  While the rash has resolved after two weeks of treatment, it is not clear to me what further potential long-term effects I will experience as a result
This spontaneous report as received from a medical assisstant refers to a patient of unknown age.    On an unknown date the patient was vaccinated with VAQTA lot # M039202 with expiration date 11-MAR-2018, for prophylaxis. Other suspect therapies included VARIVAX lot # M043582 with expiration date 28-OCT-2018, for prophylaxis. Concomitant therapies included sterile diluent (STERILE DILUENT).  On an unknown date the patient experienced incorrect product storage and no adverse event. The outcome of incorrect product storage and no adverse event is unknown. The reporter considered incorrect product storage to be not related to VAQTA and VARIVAX. The reporter considered no adverse event to be not related to VARIVAX and VAQTA.
01/19/2003 reported vomiting once that night. The morning of 01/21/2003 man noticed red dot on left leg (outer part of leg where the varivax was given). It is now noon and leg measured in diameter 8mm swollen , inflammed, and child itching at the site. Treated with 1 tsp Benadry po q 6 hours x 2 days.
Pain began this morning in groin on left leg. It now feels like I have severe (or at least what I assume it feels like) arthritis in my left hip. Hard to walk.
pt recv vax 26JAN95;on 1FEB99 tx w/ Pediazole for bronchitis & OM; on 27FEB95, dx w/ITP(platelet 15,000) and OM, pharyngitis (Grade A strep) w/ T102; pt was hospitalized & tx w/ Ig; no problem since, but MD is holding future MMR
Severe shoulder pain.  Treatment prescribed by physician includes rest, moist heat and narcotics.  Treatment initiated by patient includes antiinflammatories and rest.   Symptoms are now in their fourth week and have gotten progressively better.  Personal physician believes the vaccine was injected into the joint space of the shoulder rather than the deltoid and recommends return visit for further testing if condition persists.
No symptoms or adverse effects reported; Nurse reports 8 patients received unspecified dose of PROQUAD that was improperly stored; This spontaneous report was received from a registered nurse, referring to patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history and previous drugs reactions or allergies were not provided.  On 13-FEB-2020, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (concentration, number of administered dose, vaccination scheme frequency, route and anatomical location of vaccination were not reported; reported lot number S012530 and expiration date 20-OCT-2020) as prophylaxis. The sterile diluent (manufacturer unknown) used was properly stored.  According to the reporter, the temperature excursion was -12.8 degrees Celsius for a time frame of two hours and 38 minutes on an unspecified date (product storage error), with multiple previous temperature excursion of, the worst temperature/ was -9.8 degrees Celsius for about 112 minutes; which was detected by a digital data logger.  This is one of eight reports received from the same reporter.
approximately 5-6 hours after vaccination I developed a severe migraine that was unresponsive to tylenol and ibuprofen.  I had chills, body aches, and general malaise. The migaine remained severe throughout that night until around 5 AM the next morning when I took Tramadol which finally relieved the migraine which then became only a mild to moderate headache. I stayed on the tramadol for another 24 hours which during this time my additional symptoms were improving. By Monday morning (approximately 36 hours after receiving the vaccine) my clinical signs were almost completely resolved. After this there was only a mild headach and lethargy for an additional few days.
fever, chills, red and itchy spots on the upper body starting the day after the second vaccination. took about 3 days. After that, echo and ringing started in the left ear. A total hearing loss in the left ear about 15 days after vaccination. Steroid use for about a month but it didn't work. Afterwards, MRI and the diagnosis is acoustic neuroma. The tumor is in vestibular nerve and 3mm.
After patient received the shot and was getting up to leave, he passed out.  It took a moment to wake up.
Extreme tiredness, aching legs, pains across whole of chest, swollen left foot, shortness of breath , "pins and needles" in bothe hands at the same time as each other, loss of balance when walking, stomach pains only in the evening after eating a Small amount of food as I have put on weight recently even though I am eating the same amount ( less recently as above)  as normal for the last 70 years.
fever 102, h/a, hot flashed;collapsed 24hr p/vax;pt had adverse rxn to hep b vax;
Patient hospitalized for Perforated diverticulum of large intestine within  6 weeks of receiving covid vaccination.
Itchy lower left leg with macular papular rash. Rash the appeared on left arm and left leg. Rash continued to appear in blotches on upper thighs and arms and neck on right side. Calamine, Zyrtec, Benadryl, topical clobetasol and triamcinolone ointment and baking soda paste with no improvement. One day 8 urgent care visit that provide a kenalog injection and medrol dose pack. Continued taking Benadryl every 8 hours with slight relief. Epsom salts soak on day 9 provided some relief and decreased itching for several hours. Day 10 redness reduced substantially, and itching has reduced yet still present.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 15Dec2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 39 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Additional information: There were no known allergies. Patient received anti-viral product Paxlovid for the COVID 19 treatment (start date 14May2022 and stop date- 18May2022). On 23 May2022, patient gain experienced Rebound Covid.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Headache, tired all day 5/20/21 Hard, pink welt at shot area evening 5/20/21
On day 2 after dose 1 of the Pfizer vaccine, I developed pain, itching and swelling in two of my toes on the right foot, and one of my toes on the left foot. All three of the toes look purple and are painful to the touch, like pins and needles. One toe in particular has developed what looks like a small lesion near the toe nail. I am going to try some cortisone cream to see if it helps. Walking hurts a bit but I'm still able to go about most of my normal activities. I have had no other symptoms since receiving the first dose of the vaccine.
This spontaneous report was received from a other health professional refers to a patient of unknown age. On 26-AUG-2014 the patient was vaccinated with ROTATEQ vial, lot # K001935; expiry: 08-DEC-2015 (dose, dose # and route unspecified). No concomitant medications were reported. On 26-AUG-2014, it was reported that the patient was exposed to temperatures outside of the proper storage range. No adverse effect reported. The outcome of were exposed to temperatures outside of the proper storage range and no adverse effect reported is unknown. There was no product quality complaint (PQC) involved. This is one of several reports received from the same source.  Additional information has been requested.